AbbVie Goodwill and Intangible Assets 2012-2026 | ABBV

AbbVie goodwill and intangible assets for the quarter ending March 31, 2026 were $89.941B, a 11.77% decline year-over-year.

  • AbbVie goodwill and intangible assets for 2024 were $95.024B, a 8.1% increase from 2023.
  • AbbVie goodwill and intangible assets for 2023 were $87.903B, a 11.74% decline from 2022.
  • AbbVie goodwill and intangible assets for 2022 were $99.595B, a 8.06% decline from 2021.

AbbVie Goodwill and Intangible Assets 2012-2026 | ABBV

  • AbbVie goodwill and intangible assets for 2024 were $95.024B, a 8.1% increase from 2023.
  • AbbVie goodwill and intangible assets for 2023 were $87.903B, a 11.74% decline from 2022.
  • AbbVie goodwill and intangible assets for 2022 were $99.595B, a 8.06% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B